CD79A and infection: Targeting of an inactivated F. tularensis live vaccine strain using mouse IgG2a anti-F. tularensis LPS mAb upon FcRs at mucosal sites (via intranasal immunization) enhances immunogen-specific IgA production and confers protection against subsequent infection in an IgA-dependent manner.